Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086256

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086256

Latin America Pharmaceutical Products CMO Market, by Product Type and by Country - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

PUBLISHED:
PAGES: 151 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Pharmaceutical products CMO provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Contract manufacturing organizations offer services from development of biologics to commercial scale production.

Market Dynamics

The Latin America pharmaceutical products CMO market is expected to witness significant growth during the forecast period, owing to the increasing expansion of international pharmaceutical companies in Latin America. For instance, in April 2020, the U.S. pharmaceutical company and French corporation Gennisium Pharma entered into the exclusive agreement under which m8 Pharmaceuticals has the exclusive rights to register and commercialize a more suitable formulation of an already existing orphan drug for apnea in Mexico and Brazil. Moreover, additional pipeline products for the treatment of conditions prevalent in premature newborn patients are also included in this partnership.

Low healthcare expenditure is expected to hinder growth of Latin America pharmaceutical products CMO market. For instance, according to the survey by Brazil's Federal Council of Medicine in 2018, per capita public spending on health care in Brazil did not increase above the country's official inflation, which rose by 80% from 2008 to 2017.

Key features of the study:

  • This report provides in-depth analysis of the Latin America pharmaceutical products CMO market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Latin America pharmaceutical products CMO market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include BASF SE, Bayer AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Novartis AG, Pfizer, Inc., Pisa Farmaceutica, Fresenius SE & Co. KGaA, Takeda Pharmaceutical Company Limited, Ferring Pharmaceuticals, Inc., and Landsteiner Scientific
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Latin America pharmaceutical products CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Latin America pharmaceutical products CMO market

Detailed Segmentation:

  • Latin America Pharmaceutical Products CMO Market, By Product Type:
    • API and Ingredients
    • Finished Dosage Form
    • Pharmaceutical Packaging
  • Latin America Pharmaceutical Products CMO Market, By Country:
    • Brazil
      • By Product Type
      • API and Ingredients
      • Finished Dosage Form
      • Pharmaceutical Packaging
    • Mexico
      • By Product Type
      • API and Ingredients
      • Finished Dosage Form
      • Pharmaceutical Packaging
    • Argentina
      • By Product Type
      • API and Ingredients
      • Finished Dosage Form
      • Pharmaceutical Packaging
    • Rest of Latin America
      • By Product Type
      • API and Ingredients
      • Finished Dosage Form
      • Pharmaceutical Packaging
  • Company Profiles
    • BASF SE *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Bayer AG
    • Boehringer Ingelheim GmbH
    • Hoffmann-La Roche Ltd.
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • Pisa Farmaceutica
    • Fresenius SE & Co. KGaA
    • Takeda Pharmaceutical Company Limited
    • Ferring Pharmaceuticals, Inc.
    • Landsteiner Scientific

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI3933

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Latin America Pharmaceutical Products CMO Market, By Product Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • API and Ingredients
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Finished Dosage Form
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Pharmaceutical Packaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

5. Latin America Pharmaceutical Products CMO Market, By Country, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • Brazil
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
  • Mexico
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
  • Argentina
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
  • Rest of Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)

6. Competitive Landscape

  • Company Profiles
    • BASF SE
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bayer AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pisa Farmaceutica
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Fresenius SE & Co. KGaA
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Takeda Pharmaceutical Company Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Ferring Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Landsteiner Scientific
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

7. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!